Go Pro

Core Scientific (CORZ) 10K Form and Latest SEC Filings 2026

Core Scientific logo
$16.04 -0.92 (-5.42%)
Closing price 09/15/2026 04:00 PM Eastern
Extended Trading
$16.22 +0.18 (+1.09%)
As of 09/15/2026 07:56 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Latest Core Scientific SEC Filings & Recent Activity

Core Scientific (NASDAQ:CORZ) has submitted 439+ documents to the U.S. Securities and Exchange Commission (SEC) since 2021. For investors, these filings are the primary source of verified financial data — covering everything from annual revenue and debt levels in the 10-K, to material business events in 8-K current reports, to insider buying and selling activity in Form 4 disclosures. Key figures from these filings, including revenue, earnings, and cash flow, are summarized in Core Scientific's financial statements. The most recent filing was a Form 8-K submitted on September 10, 2026.

Form 4
Core Scientific, Inc./tx Reports Ownership Change on Aug. 26, 2026

Form 4 filings disclose changes in stock ownership by company insiders, including purchases, sales, grants, and option exercises.

View insider ownership

8-K
Core Scientific Files Current Report on Sep. 10, 2026

An 8-K is filed when a material corporate event occurs, such as an acquisition, leadership change, or financial update.

View filing

10-Q
Core Scientific Files Quarterly Report on May. 6, 2026

The 10-Q contains Core Scientific's unaudited quarterly financial statements, revenue, earnings updates, and cash flow changes between annual reports.

View earnings history

Core Scientific SEC Filing History

Browse Core Scientific's complete SEC filing history using the filters below. Filter by form type - 10-K, 10-Q, 8-K, Form 4, and more - or set a custom date range to find a filing.

DateFilerForm TypeView
09/10/2026 6:18 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/27/2026 6:07 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/26/2026 3:04 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/24/2026 3:11 PM
Core Scientific (1839341) Issuer
CRAIN ELIZABETH (1604659) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2026 3:13 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/19/2026 3:05 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/14/2026 11:13 AM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
08/14/2026 6:02 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/12/2026 3:37 PM
Core Scientific (1839341) Subject
JANE STREET GROUP, LLC (1595888) Filed by
Form SCHEDULE 13G/A
08/12/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2026 3:40 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
08/04/2026 4:37 PM
Core Scientific (1839341) Subject
Situational Awareness LP (2045724) Filed by
Form SCHEDULE 13D/A
07/31/2026 9:18 AM
Core Scientific (1839341) Subject
VANGUARD CAPITAL MANAGEMENT LLC (2100119) Filed by
Form SCHEDULE 13G
07/22/2026 3:10 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 3:16 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/20/2026 3:16 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2026 4:41 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/08/2026 3:32 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/06/2026 3:45 PM
Core Scientific (1839341) Subject
DUCHENE TODD M (1248745) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/01/2026 6:17 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
07/01/2026 6:18 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/24/2026 3:02 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
06/10/2026 3:14 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/28/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2026 3:19 PM
Core Scientific (1839341) Subject
JANE STREET GROUP, LLC (1595888) Filed by
Form SCHEDULE 13G
05/26/2026 3:02 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/20/2026 3:20 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2026 6:46 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
05/15/2026 3:49 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
05/15/2026 11:29 AM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G/A
05/13/2026 3:06 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2026 3:03 PM
Core Scientific (1839341) Issuer
Ray Jorge L. (2123780) Reporting
Form 3
Initial statement of beneficial ownership of securities  
05/06/2026 3:54 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/06/2026 3:15 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
05/06/2026 3:02 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/06/2026 6:52 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/29/2026 11:56 AM
Core Scientific (1839341) Subject
VANGUARD PORTFOLIO MANAGEMENT LLC (2100121) Filed by
Form SCHEDULE 13G
04/27/2026 4:30 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/23/2026 7:59 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/22/2026 3:01 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
What Is A Roth Conversion, And How Do I Set One Up? (Ad)

A Roth conversion moves money from a traditional IRA or employer plan into a Roth IRA, triggering income tax that year in exchange for potential tax-free qualified growth later. Key questions remain: how much to convert, where the tax payment comes from, and whether this years income leaves room. Roth IRAs also avoid lifetime required minimum distributions. A fiduciary financial advisor can help size a conversion around your specific tax situation and goals.tc pixel

Get matched with a vetted fiduciary advisor in your area today
04/21/2026 6:36 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/17/2026 8:50 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/16/2026 7:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
04/15/2026 3:02 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/08/2026 3:32 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:25 PM
Core Scientific (1839341) Issuer
DUCHENE TODD M (1248745) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/02/2026 7:26 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
04/01/2026 3:44 PM
Core Scientific (1839341) Subject
DUCHENE TODD M (1248745) Reporting
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/31/2026 3:59 PM
Core Scientific (1839341) Filer
Form DEFA14A
03/31/2026 4:01 PM
Core Scientific (1839341) Filer
Form ARS
03/31/2026 3:55 PM
Core Scientific (1839341) Filer
Form DEF 14A
03/27/2026 5:45 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4/A
03/26/2026 4:39 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
03/23/2026 7:29 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2026 7:39 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/19/2026 3:06 PM
Core Scientific (1839341) Issuer
Nygaard James P Jr (1842273) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/18/2026 4:14 PM
Core Scientific (1839341) Filer
Form 10-K/A
03/12/2026 11:55 AM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
03/10/2026 3:08 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
03/06/2026 3:13 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/04/2026 8:05 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
03/02/2026 3:44 PM
Core Scientific (1839341) Filer
Form 10-Q/A
03/02/2026 3:18 PM
Core Scientific (1839341) Filer
Form 10-K/A
02/19/2026 8:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
02/19/2026 10:56 AM
Core Scientific (1839341) Filer
Form 8-K/A
02/18/2026 4:16 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2026 10:11 AM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G/A
02/09/2026 5:08 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G/A
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Weiss Eric Stanton (2009491) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
CRAIN ELIZABETH (1604659) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Core Scientific (1839341) Issuer
Levy Jordan (1541436) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
02/06/2026 3:11 PM
Booth Jeffrey David (2009493) Reporting
Core Scientific (1839341) Issuer
Form 4
Statement of changes in beneficial ownership of securities  
01/26/2026 3:15 PM
Core Scientific (1839341) Issuer
Sullivan Adam Taylor (1980208) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
01/20/2026 8:07 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
01/07/2026 1:59 PM
Core Scientific (1839341) Subject
VANGUARD GROUP INC (102909) Filed by
Form SCHEDULE 13G/A
01/02/2026 5:26 PM
Core Scientific (1839341) Issuer
Rozov Yadin (1921268) Reporting
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2025 7:17 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
12/10/2025 5:12 PM
Citadel Securities GP LLC (1721695) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
12/01/2025 7:04 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/17/2025 5:35 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
11/13/2025 4:42 PM
Core Scientific (1839341) Subject
SUSQUEHANNA SECURITIES, LLC (1446580) Filed by
Form SCHEDULE 13G/A
11/12/2025 3:05 PM
BARCLAYS PLC (312069) Filed by
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Form SCHEDULE 13G
11/03/2025 5:42 PM
Core Scientific (1839341) Subject
Valiant Capital Management, L.P. (1452689) Filed by
Valiant Capital Management, L.P. (1452689) Filed by
Form SCHEDULE 13G
10/31/2025 4:16 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form SCHEDULE 13D/A
10/31/2025 3:27 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 3:18 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2025 9:55 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Why major institutions are piling into this digital asset now (Ad)

BlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one that gets burned with every transaction on what analysts are calling America's new financial grid. The Nasdaq has received SEC approval to move stocks onto blockchain rails, and BlackRock CEO Larry Fink dedicated his entire 2026 annual letter to this infrastructure shift. Blockchain analyst Andy Howard is calling this asset 'Digital Oil' - and says institutional buyers are already positioned.tc pixel

Get the name, the ticker, and exactly how to buy it
10/30/2025 9:28 AM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/24/2025 3:14 PM
Core Scientific (1839341) Filer
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/24/2025 3:06 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 4:20 PM
Core Scientific (1839341) Subject
CoreWeave, Inc. (1769628) Filed by
Form 425
10/22/2025 3:44 PM
Core Scientific (1839341) Filer
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/22/2025 3:44 PM
Core Scientific (1839341) Subject
Form 425
10/21/2025 4:22 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
10/17/2025 4:00 PM
Core Scientific (1839341) Subject
Two Seas Capital LP (1823138) Filed by
Form DFAN14A
(Data available from 1/1/2016 forward)

Core Scientific SEC Filings - Frequently Asked Questions

Core Scientific (CORZ) has submitted 439+ filings to the SEC since 2021. You can browse the complete history or filter by form type using the tools above.

Core Scientific's fiscal year ends on December 31. The company typically files its 10-K annual report by the end of February, covering the prior fiscal year's financial results. Key financial data from these reports is available on Core Scientific's financial statements page.

The most recent filing was a Form 8-K submitted on September 10, 2026. This was a current report on a material business event.

SEC Filing Types: 10-K, 10-Q, 8-K and More

SEC filings are legally required disclosures that public companies submit to the U.S. Securities and Exchange Commission. Unlike press releases or earnings call transcripts, these documents are filed under legal obligation — meaning the financial data they contain is audited, standardized, and subject to penalties if materially false. For investors, that makes SEC filings the most reliable primary source available for evaluating a company's true financial position.

Yes. All SEC filings are publicly available through the SEC's EDGAR database and on financial research platforms like MarketBeat. Companies are required by law to make these disclosures accessible to all investors — meaning retail investors have access to the same source documents as institutional analysts.

A 10-K is an annual report containing audited financial statements and a full review of the company's business — it is the most comprehensive filing a company makes each year. A 10-Q is a shorter, unaudited quarterly update filed three times per year between annual reports. Investors typically use the 10-K for deep fundamental analysis and the 10-Q to track whether the company is on pace with its guidance mid-year.

The most important filing for fundamental investors. Filed once per year, the 10-K contains audited financial statements, revenue and earnings trends, debt obligations, risk factors, and management's own assessment of the business. Reading the risk factors section and comparing year-over-year financials can reveal issues that don't show up in analyst summaries.

An unaudited financial update filed three times per year (the 10-K covers Q4). Investors use 10-Qs to track whether guidance is on pace, monitor changes in cash flow or inventory, and catch any mid-year shifts in business conditions before they become headline news.

Filed within four business days of a material event — earnings releases, merger announcements, executive departures, or major asset sales. Because 8-Ks are filed before media coverage catches up, they are often the fastest way to get unfiltered information directly from the company on market-moving events.

Filed within two business days whenever an executive or director buys or sells company stock. Insider purchases — especially large or clustered buys — are often interpreted as a signal of management confidence. Insider selling is more ambiguous but worth monitoring for patterns, particularly around lock-up expirations or ahead of major announcements.


Related Companies and Tools


SEC filings for NASDAQ:CORZ are sourced directly from the U.S. Securities and Exchange Commission (SEC), with the most recent filing dated 9/10/2026. New filings are added as they're published.
From Our Partners